CNS COHEN & STEERS, INC. Insider Trading

Jon Cheigh (President/CIO) sold 10,500 shares of CNS at $71.75; stock now $70.93, -10.1% from 52-week high

Jon Cheigh sold 10,500 shares (10.5K shares) for $753,375.00 ($753.4K) at $71.75 on 2026-05-26, reducing his stake to 66,670 shares (66.7K shares), a -13.6% reduction from his pre-transaction holdings of 77,170 shares (77.2K shares). The stock is currently trading at $70.93, down -10.1% from its 52-week high of $78.86, within its 52-week range of $58.39–$78.86; over 30 and 90 days the stock has moved +4.1% and +5.6% respectively. His prior trades at Cohen & Steers show mixed timing results: 1 of 3 prior sells at CNS were well-timed at the 90-day mark. The company's fundamentals show Revenue $145,639,000.00 ($145.6M) in the latest quarter with Net income $42,368,000.00 ($42.4M), Annual revenue growth (FY vs prior FY) of +7.5%, a P/E of 23.41, and Market cap of $3,646,199,704.51 ($3.6B).

GC/EVP Poli Francis C sold 19,696 shares (26.1% of holdings) at $65.24–$66.00, netting $1.3M on Feb 11–12.

Francis C, general counsel and EVP, executed three separate sales over two days, disposing of 19,696 shares for $1,293,667.04 at a blended average price of $65.68, reducing holdings from 75.4K to 55.7K shares. The current stock price of $66.14 is only 0.7% above the blended transaction price, indicating these sales occurred near current market levels and -25.7% from the 52-week high of $89.00. His prior trades at CNS (two sells in September 2024) posted 90-day returns of +5.3% and +4.7%, indicating the stock subsequently rose after those sales—a poorly-timed pattern—with 0 of 2 prior same-ticker sales achieving negative 90-day returns. Given the stock's recent weakness (−2.6% in 30 days, −25.7% from peak), the timing of this substantial stake reduction in aggregate size and across multiple days warrants context but no explicit timing signals emerge from the company's fundamentals, which show steady revenue growth of +5.7% and net income of $41.7M on quarterly revenue of $141.7M.

Cohen Martin (Director) purchases 100,000 shares of CNS across 4 transactions totaling $5,982,411.83 at blended average $59.82.

Martin Cohen acquired 100,000 shares in four separate transactions between November 18-20, 2025, increasing his holdings from 849.2K shares to 949.2K shares (+11.8%), with a total cash outlay of $5,982,411.83. The purchases occurred at a blended average price of $59.82, while the stock currently trades at $59.47, only marginally below the transaction prices. This substantial acquisition—executed across multiple trading days at relatively stable prices near current levels—occurred against a backdrop where CNS has declined 44.2% from its 52-week high of $106.60 and is down 15.9% over the past 30 days and 22.0% over 90 days. The company fundamentals remain solid, with trailing-quarter net income of $41.7M on revenue of $141.7M and a P/E of 18.47 on a $3.0B market cap, though annual revenue growth has moderated to +5.7%. The scale and timing of this director-level accumulation merit investor attention in light of the stock's recent weakness and the substantial capital commitment.

Cohen & Steers Executive Chairman Robert Hamilton purchased 25,000 shares for $1,496,880.00 on 2025-11-19 at $59.88 blended average, amid -44.2% YTD decline from 52-week high.

Robert Hamilton executed 2 separate open-market purchases totaling 25,000 shares (25.0K shares) for $1,496,880.00 ($1.5M) at blended average $59.88 on 2025-11-19, increasing his holdings from 3.87M to 3.90M shares (+0.6%). This follows a burst of recent buying activity at the same ticker—5 prior trades in early November 2025 (2025-11-03 through 2025-11-05), all outcomes not yet measurable. The timing context is material: CNS stock trades -44.2% from its 52-week high of $106.60, with 30-day and 90-day declines of -15.9% and -22.0% respectively. However, his prior cross-ticker buys (18 trades) averaged -15.2% 30-day returns, and his 0 of 0 prior buys at this or any ticker showed positive 90-day outcomes, suggesting a pattern of purchases that have not proven well-timed historically. Fundamentals remain stable (P/E 18.47, $141.7M quarterly revenue, +5.7% annual growth), but the convergence of sharply negative recent price action, frequent insider acquisitions in November, and a track record of sub-optimal timing on buys warrants attention to whether this accumulation is informed conviction or routine portfolio activity.

Cohen & Steers Executive Chairman Steers purchased 100,888 shares for $6,858,771.91 across 8 transactions at blended avg $67.98

Robert Hamilton Steers, Executive Chairman of Cohen & Steers, Inc. (CNS), executed 8 separate open-market purchases totaling 100,888 shares for $6,858,771.91 ($6.9M) between November 3–5, 2025, at a blended average price of $67.98. This increased his holdings from 3,790,296 shares to 3,891,184 shares (+2.7%). The purchases occurred when CNS was trading at -35.8% from its 52-week high of $106.60, following a 30-day gain of +3.6% and a 90-day decline of -6.2%. The company is profitable (net income $41,711,000.00 on revenue $141,720,000.00 in the latest quarter) with modest annual growth of +5.7% and a P/E ratio of 21.25. The timing of this accumulation—concentrated over three trading days at prices notably below the recent high—may signal Steers' assessment of value, though his prior 5 same-ticker purchases (all on 2025-10-21 and 2025-10-22) have not yet reached measurable 90-day outcome dates.

Cohen & Steers Executive Chairman buys 40,539 shares for $2,846,316.07 across 10 trades, Oct 20-22.

STEERS ROBERT HAMILTON, Executive Chairman of Cohen & Steers, Inc. (CNS), executed 10 separate purchases totaling 40,539 shares for $2,846,316.07 at a blended average price of $70.21 across October 20–22, 2025. His post-transaction holdings increased to 3,858,709 shares from 3,818,170 shares, a +1.1% increase in his stake. The purchases occurred as CNS traded at a 52-week low relative to its range of $64.53–$106.60, with the current price $68.84 sitting -35.4% from the 52-week high. The company's fundamentals remain solid with revenue of $136,126,000.00 and net income of $36,849,000.00 in the latest quarter, though the stock has declined -9.8% over the prior 90 days even as annual revenue growth stands at +5.7%. The multi-transaction pattern and magnitude suggest sustained acquisitional activity by the company's top executive during a period of price weakness relative to the year-to-date trajectory.

CNS President/CIO Cheigh Jon sold 25,500 shares at $80.01 on 2025-05-09 for $2,040,255.00, reducing holdings by -15.2%.

Cheigh Jon executed a material open-market sale of 25,500 shares (15.2% of his prior holdings), bringing his position from 167,931 to 142,431 shares at a sale price of $80.01. The current stock price of $82.87 sits -22.3% below the 52-week high of $106.60, and while the stock has gained 12.6% over the past 30 days, it remains down 3.9% over 90 days. Notably, his prior two sales at this ticker in July 2024 both produced positive 90-day returns (5.3% and 4.4%), indicating his prior sales at CNS were not well-timed from a downside-protection perspective—the stock rose after he sold. With Cohen & Steers reporting $134.5M in revenue and $39.8M net income at a 26.91 P/E, the fundamentals show moderate growth (+5.7% annual) but elevated valuation relative to recent price weakness. This sale represents a significant reduction in a director-level position but does not contradict the pattern of prior CNS sales preceding gains.

CNS EVP Charles Daniel P sold 6,868 shares for $712,462.64; post-transaction holdings of 46,243 shares represent 12.9% reduction from 53,111 shares.

Charles Daniel P, Executive Vice President at Cohen & Steers Inc., executed 2 separate sales totaling 6,868 shares for $712,462.64 at blended average price of $103.74. The sale reduces his equity stake by 12.9%, from 53,111 shares to 46,243 shares. The transaction occurred when the stock was trading near its 52-week range highs (current price $102.90 is 3.5% below the 52-week high of $106.60), and equity value has appreciated 17.9% over the prior 90 days. Against this backdrop of strong recent price momentum, the sale's magnitude suggests a material reduction in his ownership exposure to the company. No FLAGS or TRACK RECORD were provided, so the timing context relative to his historical trading pattern cannot be assessed.

GC/EVP Francis Poli sold 15,000 shares ($1.4M) at avg $94.08; holds 64.9K post-sale as stock hits 52-week high.

POLI FRANCIS C, General Counsel and EVP, executed 2 separate sales totaling 15,000 shares on 2024-09-16 for $1,411,218.36, reducing his holdings by 18.8% from 79,866 to 64,866 shares. The sales occurred at an average price of $94.08, while the stock's current price is $96.28 (at its 52-week high of $96.28 after +13.7% gains over 30 days and +36.0% over 90 days). The company's recent fundamentals show revenue of $121,721,000.00 and net income of $31,771,000.00 in the latest quarter, though annual revenue has contracted 13.6% year-over-year and the stock trades at a P/E of 38.06. The sale represents a material reduction in an insider's equity stake while the stock is appreciating sharply, warranting examination of whether this reflects personal financial planning or other considerations given the company's mixed operational backdrop.

Cohen & Steers CIO Cheigh Jon sold 12,500 shares at blended average $84.08, reducing stake to 155.3K shares

Cheigh Jon, Chief Investment Officer and EVP at Cohen & Steers, executed 2 separate sales totaling 12,500 shares for $1,050,987.89 on 2024-07-25 at a blended average price of $84.08. The sale reduced his holdings by 7.4%, from 167.8K to 155.3K shares post-transaction. The stock currently trades at $86.91, within 0.0% of its 52-week high of $86.91, and has appreciated 23.8% over the prior 30 days. The company reported latest-quarter revenue of $122.7M, net income of $34.0M, and carries a P/E of 34.35 with a market cap of $4.4B, though annual revenue growth is -13.6%. The transaction timing aligns with recent strength in the stock price; the insider's sale occurred near all-time highs after substantial short-term gains.